Determination of ebselen-sensitive reactive oxygen metabolites(ebROM) in human serum based upon N,N′-diethyl-1,4-phenylenediamine oxidation

Loading...
Thumbnail Image
Can’t use the file because of accessibility barriers? Contact us with the title of the item, permanent link, and specifics of your accommodation need.

Date

2012-12

Journal Title

Journal ISSN

Volume Title

Publisher

Clinica Chimica Acta

Abstract

Background: Oxidative stress occurs through free radical- and non-radical-mediated oxidative mechanisms, but these are poorly discriminated by most assays. A convenient assay for oxidants in human serum is based upon the Fe2+-dependent decomposition of peroxides to oxidize N,N′-diethyl-1,4-phenylenediamine (DEPPD) to a stable radical cation which can be measured spectrophotometrically. Methods: We investigated modification of the DEPPD oxidation assay to discriminate color formation due to non-radical oxidants, including hydroperoxides and endoperoxides, which are sensitive to ebselen. Results: Use of serum, which has been pretreated with ebselen as a reference, provides a quantitative assay for non-radical, reactive oxidant species in serum, including hydroperoxides, endoperoxides and epoxides. In a set of 35 human serum samples, non-radical oxidants largely accounted for DEPPD oxidation in 86% of the samples while the remaining 14% had considerable contribution from other redox-active chemicals. Conclusions: The simple modification in which ebselen-pretreated sample is used as a reference provides means to quantify non-radical oxidants in human serum. Application of this approach could enhance understanding of the contribution of different types of oxidative stress to disease.

Description

Postprint, author's accepted manuscript

Keywords

Oxidative stress, cardiovascular disease, peroxides, hydroperoxides, endoperoxides, epoxides

Citation

Liang, Y., Roede, J.R., Dikalov, S., Gletsu-Miller, N., Dudley, S.C., Quyyumi, A., Jones, D.P. Determination of ebselen-sensitive reactive oxygen metabolites (ebROM) in human serum based upon N,N’-diethyl-1,4-phenylenediamine oxidation. Clinica Chimica Acta, 414:1-6, 2012

Journal

Relation

Rights

Type

Article